US FDA’s New Stricter Guidelines for Emergency Approval of COVID-19 Vaccine Blocked by White House
The White House chief of staff has objected to provisions in the stricter guidelines proposed by the US Food and Drug Administration (FDA Silver Spring, MD, USA) that that would push the emergency approval of a COVID-19 vaccine past US Election Day. More...07 Oct 2020
Novel Rapid Antigen Assay Detects SARS-CoV-2 in Saliva in 10 Minutes
Veravas, Inc. (Charleston, SC, USA) has developed its VeraTest SARS-CoV-2 Rapid Antigen Assay, based on the company’s patent-pending VeraPrep technology and a proprietary novel antibody fragment with high specificity to the SARS-Cov-2 spike protein. More...06 Oct 2020
EKF Diagnostics’ PrimeStore MTM Successfully Evaluated by Public Health England for SARS-CoV-2 Inactivation
EKF Diagnostics’ (Cardiff, UK) novel viral transport media PrimeStore MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation in a new study published by Public Health England (PHE). More...06 Oct 2020
US Labs Increase COVID-19 Testing Capacity but Facing Shortage of Supplies, Finds NILA Survey
A survey of community and regional laboratories in the US has revealed a potential collective increase in COVID-19 testing capacity, although difficulties persist in accessing the necessary testing supplies. More...06 Oct 2020
Automatic Point-of-Care System Measures COVID-19 Antibodies Along with HbA1c, CRP, U-Albumin within 3 Minutes
A new automatic point-of-care system measures COVID-19 antibodies along with HbA1c, glycated albumin, hemoglobin, C-reactive protein and U-Albumin within just three minutes. More...06 Oct 2020
Qiagen to Complement COVID-19 Testing Portfolio with Novel Kit That Simplifies and Accelerates PCR Analysis for Research
QIAGEN N.V. (Venlo, Netherlands) plans to launch a novel straightforward approach to viral RNA epidemiology that will significantly simplify and accelerate PCR analysis and remove key testing bottlenecks for SARS-CoV-2 and other RNA viruses. More...06 Oct 2020
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Documentation System For Blood Banks
HettInfo II
New
Cannulating Sphincterotome
TRUEtome
In Other News
Approved MS Drug Inhibits Replication of SARS-CoV-2 in Human Lung Cells and Fights Immune Reaction Killing COVID-19 Patients
New COVID-19 Testing Method Delivers Accurate Results Without Using Reagents
New Sensor Rapidly Detects COVID-19 Infection Status, Severity, and Immunity
Quidel Receives FDA EUA for First Rapid Antigen Combination ABC Test for Influenza A+B and COVID-19
LabCorp’s Innovative SARS-CoV-2 RNA Extraction Method Secures FDA Emergency Use Authorization
Beckman Coulter Granted FDA EUA for COVID-19 Inflammatory Response Immunoassay
COVID-19 Machine-Learning Algorithm Secures FDA Emergency Use Authorization
Gilead’s Remdesivir (Veklury) to Be Reviewed by EU Regulator After COVID-19 Patients Report Acute Kidney Injury
Enlivex Reports Positive Allocetra Trial Results in COVID-19 Patients in Severe/Critical Condition
COVID 19 - Medela’s Portable Medical Surgical and Airway Suction Devices Offers Safer Alternative to Piped Vacuum Systems
FDA-Approved Drug to Lower Blood Sugar Nearly Halves Mortality in Diabetic Patients Hospitalized With COVID-19
Potential Micro-Magnetic Theranostic Measures COVID-19 Viral-Load with MRI
Engineered RNA-Targeting Compounds Break COVID-19’s Clutch by Disabling SARS-CoV-2’s Replication Engine
Some SARS-CoV-2 Antibodies Are More Protective Than Others in Preventing COVID-19 Reinfection, Finds Study
New Diagnostic Tool Identifies and Treats COVID-19 Patients at Serious Risk of Developing Cytokine Storm
Vivera Pharmaceuticals Launches Two New COVID-19 Diagnostic Tests for Detection of SARS-CoV-2 Antigens
Moderna’s COVID-19 Vaccine Won’t Be Ready Until Spring of Next Year, Says CEO
AstraZeneca’s COVID-19 Vaccine Study Being Investigated Further by US FDA; EU Regulator Starts “Rolling Review” to Expedite Approval
AI Algorithm Detects COVID-19 in Lungs by Analyzing CT Scans With 90% Accuracy
Regeneron's COVID-19 Antibody Cocktail Reduces Viral Levels and Speeds Recovery in Early Data
Huge COVID-19 Testing Demand to Drive Global Point-of-Care Diagnostics Market to USD 11.7 Billion by 2024
New, Portable Lab-on-a-Chip Identifies Concentration of COVID-19 Antibodies in Human Blood In 15 Minutes
BD Receives CE Mark for Portable, Rapid Point-of-Care COVID-19 Antigen Test That Detects SARS-CoV-2 in 15 Minutes
